Sibutramine
Back to searchMolecule Structure
Scientific Name
Sibutramine
Description of the Drug
Sibutramine is a norepinephrine, serotonin and dopamine reuptake inhibitor indicated to assist with weight loss in obesity.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01105
http://www.drugbank.ca/drugs/DB01105
Brand Name(s)
Reductil
Company Owner(s)
Abbott Laboratories Pharmaceutical Products Div
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Monoamine transporter | PROTEIN FAMILY | INHIBITOR | CHEMBL2363064 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL2955 | ||
| PharmGKB | PA451344 | ||
| Human Metabolome Database | HMDB0015237 | ||
| DrugBank | DB01105 | ||
| PubChem: Thomson Pharma | 14750864 | ||
| PubChem | 5210 | ||
| Mcule | MCULE-6656338642 | ||
| LINCS | LSM-5000 | ||
| Nikkaji | J247.963J | ||
| BindingDB | 84742 | ||
| EPA CompTox Dashboard | DTXSID1023578 | ||
| DrugCentral | 2440 | ||
| ChemicalBook | CB5708493 | CB3783665 | |
| Guide to Pharmacology | 2586 | ||
| rxnorm | SIBUTRAMINE | SIBUTRAMINE HYDROCHLORIDE | SIBUTRAMINE HYDROCHLORIDE MONOHYDRATE |
| KEGG Ligand | C07247 | ||
| ChEBI | 9137 |
